Today's Information |
Provided by: Savior Lifetec Corporation | |||||
SEQ_NO | 2 | Date of announcement | 2022/06/08 | Time of announcement | 17:59:21 |
Subject | Announcement The Company and Shenzhen China Resources GOSUN Pharmaceuticals signed an exclusive sales contract for Ertapenem in the mainland market | ||||
Date of events | 2022/06/08 | To which item it meets | paragraph 10 | ||
Statement | 1.Date of occurrence of the event:2022/06/08 2.Counterparty to the contract or commitment: Shenzhen China Resources GOSUN Pharmaceuticals Co.,Ltd 3.Relationship with the Company:None 4.Starting and ending dates (or rescission date) of the contract or commitment:From the date of signing the contract 5.Major content (not applicable where rescinded): The company signed a sales contract with Shenzhen China Resources GOSUN Pharmaceuticals, authorizing the company to exclusively sell the company's ertapenem injection products in the mainland market. 6.Restrictive covenants (not applicable where rescinded):Privacy Policy 7.Commitment (not applicable where rescinded):None 8.Any other important agreement (not applicable where rescinded):None 9.Effect on company finances and business: Accelerating the introduction of ertapenem into the Chinese mainland market will help increase the global market share of the company's products 10.Concrete purpose/objective:Through this cooperation project, the company will open a new milestone in the company's mainland market sales. 11.Any other matters that need to be specified: It can only be sold after obtaining a drug certificate in cooperation with the sales area. For financial or business information, please refer to the information published by the Company on the Public Information Observatory. |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Savior Lifetec Corporation published this content on 08 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2022 10:01:04 UTC.